{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T03:39:15Z","timestamp":1772163555724,"version":"3.50.1"},"reference-count":92,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1016\/j.numecd.2007.05.001","type":"journal-article","created":{"date-parts":[[2007,8,21]],"date-time":"2007-08-21T12:56:51Z","timestamp":1187701011000},"page":"616-628","source":"Crossref","is-referenced-by-count":23,"title":["Increasing apoA-I production as a target for CHD risk reduction"],"prefix":"10.1016","volume":"17","author":[{"given":"Stefan P.J.","family":"Dullens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jogchum","family":"Plat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald P.","family":"Mensink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.numecd.2007.05.001_bib1","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1161\/01.ATV.0000022850.59845.E0","article-title":"Value of HDL cholesterol, apolipoprotein A-I, lipoprotein A-I, and lipoprotein A-I\/A-II in prediction of coronary heart disease: the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction","volume":"22","author":"Luc","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"Suppl.","key":"10.1016\/j.numecd.2007.05.001_bib2","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/0021-9150(96)05852-2","article-title":"High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport","volume":"124","author":"Assmann","year":"1996","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.numecd.2007.05.001_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0021-9150(01)00651-7","article-title":"HDL and arteriosclerosis: beyond reverse cholesterol transport","volume":"161","author":"Nofer","year":"2002","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.numecd.2007.05.001_bib4","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0022-2275(20)42034-6","article-title":"Differential tissue-specific expression of human apoA-I and apoA-II","volume":"32","author":"Eggerman","year":"1991","journal-title":"J Lipid Res"},{"key":"10.1016\/j.numecd.2007.05.001_bib5","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1021\/bi002025g","article-title":"Characterization of the maturation of human pro-apolipoprotein A-I in an in vitro model","volume":"40","author":"Pyle","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.numecd.2007.05.001_bib6","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1194\/jlr.M200414-JLR200","article-title":"Role of the hepatic ABCA1 transporter in modulating intrahepatic cholesterol and plasma HDL cholesterol concentrations","volume":"44","author":"Basso","year":"2003","journal-title":"J Lipid Res"},{"key":"10.1016\/j.numecd.2007.05.001_bib7","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1194\/jlr.M400402-JLR200","article-title":"On the hepatic mechanism of HDL assembly by the ABCA1\/apoA-I pathway","volume":"46","author":"Tsujita","year":"2005","journal-title":"J Lipid Res"},{"key":"10.1016\/j.numecd.2007.05.001_bib8","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1172\/JCI116384","article-title":"Increased plasma and renal clearance of an exchangeable pool of apolipoprotein A-I in subjects with low levels of high density lipoprotein cholesterol","volume":"91","author":"Horowitz","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.numecd.2007.05.001_bib9","doi-asserted-by":"crossref","first-page":"26898","DOI":"10.1074\/jbc.M010708200","article-title":"The mechanism of the remodeling of high density lipoproteins by phospholipid transfer protein","volume":"276","author":"Settasatian","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.numecd.2007.05.001_bib10","doi-asserted-by":"crossref","first-page":"9774","DOI":"10.1073\/pnas.0403506101","article-title":"ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins","volume":"101","author":"Wang","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.numecd.2007.05.001_bib11","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0005-2760(91)90132-2","article-title":"Cholesterol transport between cells and high-density lipoproteins","volume":"1085","author":"Johnson","year":"1991","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.numecd.2007.05.001_bib12","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1021\/bi00174a047","article-title":"Specific binding of free apolipoprotein A-I to a high-affinity binding site on HepG2 cells: characterization of two high-density lipoprotein sites","volume":"33","author":"Barbaras","year":"1994","journal-title":"Biochemistry"},{"key":"10.1016\/j.numecd.2007.05.001_bib13","doi-asserted-by":"crossref","DOI":"10.1007\/s00018-005-5194-0","article-title":"The nucleotide receptor P2Y(13) is a key regulator of hepatic High-Density Lipoprotein (HDL) endocytosis","author":"Jacquet","year":"2005","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.numecd.2007.05.001_bib14","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nature01250","article-title":"Ectopic beta-chain of ATP synthase is an apolipoprotein A-I receptor in hepatic HDL endocytosis","volume":"421","author":"Martinez","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.numecd.2007.05.001_bib15","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S1043-2760(02)00589-1","article-title":"Lipases and HDL metabolism","volume":"13","author":"Jin","year":"2002","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.numecd.2007.05.001_bib16","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0021-9150(01)00447-6","article-title":"The impact of phospholipid transfer protein (PLTP) on HDL metabolism","volume":"155","author":"Huuskonen","year":"2001","journal-title":"Atherosclerosis"},{"issue":"Suppl. A","key":"10.1016\/j.numecd.2007.05.001_bib17","first-page":"5A","article-title":"Cholesterol and lipids in the risk of coronary artery disease\u2014the Framingham Heart Study","volume":"4","author":"Castelli","year":"1988","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.numecd.2007.05.001_bib18","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/00041433-200012000-00010","article-title":"Prevention of coronary heart disease by raising high-density lipoprotein cholesterol?","volume":"11","author":"von Eckardstein","year":"2000","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.numecd.2007.05.001_bib19","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.numecd.2006.01.012","article-title":"biological and physiopathological consequences","volume":"16","author":"Norata","year":"2006","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.numecd.2007.05.001_bib20","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.numecd.2004.09.004","article-title":"Gene polymorphisms affecting HDL-cholesterol levels in the normolipidemic population","volume":"15","author":"Miltiadous","year":"2005","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.numecd.2007.05.001_bib21","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/11905","article-title":"Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency","volume":"22","author":"Brooks-Wilson","year":"1999","journal-title":"Nat Genet"},{"key":"10.1016\/j.numecd.2007.05.001_bib22","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1161\/01.ATV.16.12.1416","article-title":"A cysteine-containing truncated apo A-I variant associated with HDL deficiency","volume":"16","author":"Moriyama","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.numecd.2007.05.001_bib23","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1097\/01.CCM.0000059724.08290.51","article-title":"Lipoprotein metabolism in patients with severe sepsis","volume":"31","author":"van Leeuwen","year":"2003","journal-title":"Crit Care Med"},{"key":"10.1016\/j.numecd.2007.05.001_bib24","first-page":"1701","article-title":"Lipid profiles in untreated patients with rheumatoid arthritis","volume":"26","author":"Park","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.numecd.2007.05.001_bib25","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.numecd.2005.01.004","article-title":"Relationship of C-reactive protein with components of the metabolic syndrome in normal-weight and overweight elderly","volume":"15","author":"Hoekstra","year":"2005","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"Suppl.","key":"10.1016\/j.numecd.2007.05.001_bib26","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1567-5688(02)00044-2","article-title":"HDL therapy for the acute treatment of atherosclerosis","volume":"3","author":"Newton","year":"2002","journal-title":"Atheroscler"},{"key":"10.1016\/j.numecd.2007.05.001_bib27","doi-asserted-by":"crossref","first-page":"39093","DOI":"10.1074\/jbc.M206770200","article-title":"ApoA-I structure on discs and spheres. Variable helix registry and conformational states","volume":"277","author":"Li","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.numecd.2007.05.001_bib28","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0022-2836(02)01143-9","article-title":"Molecular dynamics simulations on discoidal HDL particles suggest a mechanism for rotation in the apo A-I belt model","volume":"324","author":"Klon","year":"2002","journal-title":"J Mol Biol"},{"key":"10.1016\/j.numecd.2007.05.001_bib29","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/353265a0","article-title":"Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI","volume":"353","author":"Rubin","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.numecd.2007.05.001_bib30","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1161\/01.CIR.99.1.105","article-title":"Somatic gene transfer of human ApoA-I inhibits atherosclerosis progression in mouse models","volume":"99","author":"Benoit","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2007.05.001_bib31","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0022-2275(20)37227-8","article-title":"ApoA-I knockout mice: characterization of HDL metabolism in homozygotes and identification of a post-RNA mechanism of apoA-I up-regulation in heterozygotes","volume":"38","author":"Plump","year":"1997","journal-title":"J Lipid Res"},{"key":"10.1016\/j.numecd.2007.05.001_bib32","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1161\/hc0302.103711","article-title":"Oral administration of an Apo A-I mimetic Peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol","volume":"105","author":"Navab","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2007.05.001_bib33","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1161\/01.CIR.0000070589.61860.A9","article-title":"L-4F, an apolipoprotein A-1 mimetic, dramatically improves vasodilation in hypercholesterolemia and sickle cell disease","volume":"107","author":"Ou","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2007.05.001_bib34","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1161\/01.RES.0000018422.31717.EE","article-title":"Recombinant apolipoprotein A-I(Milano) infusion into rabbit carotid artery rapidly removes lipid from fatty streaks","volume":"90","author":"Chiesa","year":"2002","journal-title":"Circ Res"},{"key":"10.1016\/j.numecd.2007.05.001_bib35","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1001\/jama.290.17.2292","article-title":"Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial","volume":"290","author":"Nissen","year":"2003","journal-title":"Jama"},{"key":"10.1016\/j.numecd.2007.05.001_bib36","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1056\/NEJMoa031766","article-title":"Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol","volume":"350","author":"Brousseau","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2007.05.001_bib37","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1056\/NEJMoa071359","article-title":"Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia","volume":"356","author":"Kastelein","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2007.05.001_bib38","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1161\/01.ATV.0000256728.60226.77","article-title":"The failure of torcetrapib: was it the molecule or the mechanism?","volume":"27","author":"Tall","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.numecd.2007.05.001_bib39","doi-asserted-by":"crossref","first-page":"D456","DOI":"10.2741\/Zannis","article-title":"Transcriptional regulation of the human apolipoprotein genes","volume":"6","author":"Zannis","year":"2001","journal-title":"Front Biosci"},{"key":"10.1016\/j.numecd.2007.05.001_bib40","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0014-5793(03)01429-7","article-title":"Expression and secretion of human apolipoprotein A-I in the heart","volume":"557","author":"Baroukh","year":"2004","journal-title":"FEBS Lett"},{"key":"10.1016\/j.numecd.2007.05.001_bib41","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1515\/CCLM.2003.064","article-title":"Regulatory gene mutations affecting apolipoprotein gene expression: functions and regulatory behavior of known genes may guide future pharmacogenomic approaches to therapy","volume":"41","author":"Zannis","year":"2003","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.numecd.2007.05.001_bib42","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00041433-200104000-00012","article-title":"Transcriptional regulatory mechanisms of the human apolipoprotein genes in vitro and in vivo","volume":"12","author":"Zannis","year":"2001","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.numecd.2007.05.001_bib43","doi-asserted-by":"crossref","first-page":"8402","DOI":"10.1074\/jbc.271.14.8402","article-title":"Binding specificity and modulation of the ApoA-I promoter activity by homo- and heterodimers of nuclear receptors","volume":"271","author":"Tzameli","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.numecd.2007.05.001_bib44","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1126\/science.1899293","article-title":"Regulation of the apolipoprotein AI gene by ARP-1, a novel member of the steroid receptor superfamily","volume":"251","author":"Ladias","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.numecd.2007.05.001_bib45","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1172\/JCI118687","article-title":"Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice","volume":"97","author":"Berthou","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.numecd.2007.05.001_bib46","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1093\/nar\/21.5.1205","article-title":"HNF-4 increases activity of the rat Apo A1 gene","volume":"21","author":"Chan","year":"1993","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.numecd.2007.05.001_bib47","doi-asserted-by":"crossref","first-page":"13185","DOI":"10.1016\/S0021-9258(17)36817-5","article-title":"Transcriptional repression of apolipoprotein AI gene expression by orphan receptor ARP-1","volume":"269","author":"Ge","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.numecd.2007.05.001_bib48","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1093\/nar\/23.9.1536","article-title":"Transcriptional activation by the orphan nuclear receptor ARP-1","volume":"23","author":"Malik","year":"1995","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.numecd.2007.05.001_bib49","doi-asserted-by":"crossref","first-page":"31012","DOI":"10.1016\/S0021-9258(18)47383-8","article-title":"Negative regulation of the human apolipoprotein A-I promoter by fibrates can be attenuated by the interaction of the peroxisome proliferator-activated receptor with its response element","volume":"269","author":"Vu-Dac","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.numecd.2007.05.001_bib50","doi-asserted-by":"crossref","first-page":"5306","DOI":"10.1073\/pnas.091021198","article-title":"A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport","volume":"98","author":"Oliver","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.numecd.2007.05.001_bib51","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1194\/jlr.M400400-JLR200","article-title":"Reduced cholesterol absorption upon PPARdelta activation coincides with decreased intestinal expression of NPC1L1","volume":"46","author":"van der Veen","year":"2005","journal-title":"J Lipid Res"},{"key":"10.1016\/j.numecd.2007.05.001_bib52","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/358771a0","article-title":"Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors","volume":"358","author":"Kliewer","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.numecd.2007.05.001_bib53","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1172\/JCI0214505","article-title":"Bile acid-activated nuclear receptor FXR suppresses apolipoprotein A-I transcription via a negative FXR response element","volume":"109","author":"Claudel","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.numecd.2007.05.001_bib54","doi-asserted-by":"crossref","first-page":"28220","DOI":"10.1016\/S0021-9258(18)46917-7","article-title":"Activation of apolipoprotein AI gene transcription by the liver-enriched factor HNF-3","volume":"269","author":"Harnish","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.numecd.2007.05.001_bib55","doi-asserted-by":"crossref","first-page":"5084","DOI":"10.1021\/bi035764g","article-title":"Contribution of the hormone-response elements of the proximal ApoA-I promoter, ApoCIII enhancer, and C\/EBP binding site of the proximal ApoA-I promoter to the hepatic and intestinal expression of the ApoA-I and ApoCIII genes in transgenic mice","volume":"43","author":"Kan","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.numecd.2007.05.001_bib56","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1194\/jlr.M300179-JLR200","article-title":"Regulation of apoA-I gene expression: mechanism of action of estrogen and genistein","volume":"45","author":"Lamon-Fava","year":"2004","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.numecd.2007.05.001_bib57","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1021\/bi026984h","article-title":"Insulin induction of apolipoprotein AI, role of Sp1","volume":"42","author":"Lam","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.numecd.2007.05.001_bib58","doi-asserted-by":"crossref","first-page":"13822","DOI":"10.1074\/jbc.M011031200","article-title":"Epidermal growth factor induction of apolipoprotein A-I is mediated by the Ras-MAP kinase cascade and Sp1","volume":"276","author":"Zheng","year":"2001","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.numecd.2007.05.001_bib59","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0022-2275(20)31505-4","article-title":"Regulation of human apolipoprotein A-I gene expression by equine estrogens","volume":"42","author":"Zhang","year":"2001","journal-title":"J Lipid Res"},{"key":"10.1016\/j.numecd.2007.05.001_bib60","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0014-5793(96)00782-X","article-title":"ER beta: identification and characterization of a novel human estrogen receptor","volume":"392","author":"Mosselman","year":"1996","journal-title":"FEBS Lett"},{"key":"10.1016\/j.numecd.2007.05.001_bib61","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1016\/S0022-2275(20)37139-X","article-title":"Effects of dimethyl sulfoxide on apolipoprotein A-I in the human hepatoma cell line, HepG2","volume":"38","author":"Tam","year":"1997","journal-title":"J Lipid Res"},{"key":"10.1016\/j.numecd.2007.05.001_bib62","doi-asserted-by":"crossref","first-page":"14954","DOI":"10.1074\/jbc.272.23.14954","article-title":"Regulation of human apolipoprotein A-I gene expression by gramoxone","volume":"272","author":"Cuthbert","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.numecd.2007.05.001_bib63","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1093\/nar\/28.24.4919","article-title":"The SP1 sites of the human apoCIII enhancer are essential for the expression of the apoCIII gene and contribute to the hepatic and intestinal expression of the apoA-I gene in transgenic mice","volume":"28","author":"Georgopoulos","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.numecd.2007.05.001_bib64","first-page":"632","article-title":"Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer","volume":"61","author":"Campbell-Thompson","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.numecd.2007.05.001_bib65","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1073\/pnas.80.9.2574","article-title":"Intracellular and extracellular processing of human apolipoprotein A-I: secreted apolipoprotein A-I isoprotein 2 is a propeptide","volume":"80","author":"Zannis","year":"1983","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.numecd.2007.05.001_bib66","doi-asserted-by":"crossref","first-page":"34540","DOI":"10.1074\/jbc.M206074200","article-title":"Restriction of apolipoprotein A-IV gene expression to the intestine villus depends on a hormone-responsive element and parallels differential expression of the hepatic nuclear factor 4alpha and gamma isoforms","volume":"277","author":"Sauvaget","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.numecd.2007.05.001_bib67","doi-asserted-by":"crossref","first-page":"4954","DOI":"10.1074\/jbc.274.8.4954","article-title":"The \u2212700\/\u2212310 fragment of the apolipoprotein A-IV gene combined with the \u2212890\/\u2212500 apolipoprotein C-III enhancer is sufficient to direct a pattern of gene expression similar to that for the endogenous apolipoprotein A-IV gene","volume":"274","author":"Le Beyec","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.numecd.2007.05.001_bib68","doi-asserted-by":"crossref","first-page":"278","DOI":"10.5551\/jat.11.278","article-title":"Fenofibrate effectively reduces remnants, and small dense LDL, and increases HDL particle number in hypertriglyceridemic men\u2014a nuclear magnetic resonance study","volume":"11","author":"Ikewaki","year":"2004","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.numecd.2007.05.001_bib69","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(05)67667-2","article-title":"Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial","volume":"366","author":"Keech","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.numecd.2007.05.001_bib70","first-page":"431","article-title":"Fibric acid derivatives in cardiovascular disease prevention: results from the large clinical trials","volume":"17","author":"Robins","year":"2006","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.numecd.2007.05.001_bib71","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1161\/CIRCULATIONAHA.105.565135","article-title":"Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial","volume":"113","author":"Otvos","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2007.05.001_bib72","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1210\/me.2003-0327","article-title":"The protein kinase C signaling pathway regulates a molecular switch between transactivation and transrepression activity of the peroxisome proliferator-activated receptor alpha","volume":"18","author":"Blanquart","year":"2004","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.numecd.2007.05.001_bib73","doi-asserted-by":"crossref","first-page":"50K","DOI":"10.1016\/j.amjcard.2005.08.008","article-title":"High-density lipoprotein as a therapeutic target: clinical evidence and treatment strategies","volume":"96","author":"Toth","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.numecd.2007.05.001_bib74","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.atherosclerosis.2004.06.022","article-title":"Comparison of the impact of atorvastatin and simvastatin on apoA-I kinetics in men","volume":"178","author":"Mauger","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.numecd.2007.05.001_bib75","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1172\/JCI10852","article-title":"Statin-induced inhibition of the Rho-signaling pathway activates PPARalpha and induces HDL apoA-I","volume":"107","author":"Martin","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.numecd.2007.05.001_bib76","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11883-006-0063-3","article-title":"The effects of statins on high-density lipoproteins","volume":"8","author":"Schaefer","year":"2006","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.numecd.2007.05.001_bib77","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s11883-004-0104-8","article-title":"The role of fibrates in managing hyperlipidemia: mechanisms of action and clinical efficacy","volume":"6","author":"Fazio","year":"2004","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.numecd.2007.05.001_bib78","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/00043798-200202000-00005","article-title":"Atorvastatin versus four statin-fibrate combinations in patients with familial combined hyperlipidaemia","volume":"9","author":"Athyros","year":"2002","journal-title":"J Cardiovasc Risk"},{"key":"10.1016\/j.numecd.2007.05.001_bib79","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.2337\/diacare.25.7.1198","article-title":"Atorvastatin and micronized fenofibrate alone and in combination in type 2 diabetes with combined hyperlipidemia","volume":"25","author":"Athyros","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2007.05.001_bib80","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/07315724.2004.10719353","article-title":"Effect of low and high fat diets on nutrient intakes and selected cardiovascular risk factors in sedentary men and women","volume":"23","author":"Meksawan","year":"2004","journal-title":"J Am Coll Nutr"},{"key":"10.1016\/j.numecd.2007.05.001_bib81","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1093\/ajcn\/77.5.1146","article-title":"Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials","volume":"77","author":"Mensink","year":"2003","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.numecd.2007.05.001_bib82","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.metabol.2004.05.011","article-title":"Induction of the apolipoprotein AI promoter by Sp1 is repressed by saturated fatty acids","volume":"53","author":"Haas","year":"2004","journal-title":"Metabolism"},{"key":"10.1016\/j.numecd.2007.05.001_bib83","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/S0022-2275(20)31537-6","article-title":"Alcohol consumption stimulates early steps in reverse cholesterol transport","volume":"42","author":"van der Gaag","year":"2001","journal-title":"J Lipid Res"},{"key":"10.1016\/j.numecd.2007.05.001_bib84","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/j.1530-0277.1992.tb00693.x","article-title":"Effect of ethanol on lipoprotein secretion in two human hepatoma cell lines, HepG2 and Hep3B","volume":"16","author":"Tam","year":"1992","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.numecd.2007.05.001_bib85","doi-asserted-by":"crossref","DOI":"10.1210\/er.2005-0013","article-title":"The Effect of Select Nutrients on Serum High-Density Lipoprotein Cholesterol and Apolipoprotein A-I Levels","author":"Mooradian","year":"2006","journal-title":"Endocr Rev"},{"key":"10.1016\/j.numecd.2007.05.001_bib86","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0955-2863(02)00284-X","article-title":"Niacin and cholesterol: role in cardiovascular disease (review)","volume":"14","author":"Ganji","year":"2003","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.numecd.2007.05.001_bib87","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0021-9150(95)05572-E","article-title":"9-cis-retinoic acid increases apolipoprotein AI secretion and mRNA expression in HepG2 cells","volume":"117","author":"Haghpassand","year":"1995","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.numecd.2007.05.001_bib88","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1161\/CIRCULATIONAHA.106.171052","article-title":"Soy protein, isoflavones, and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee","volume":"113","author":"Sacks","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2007.05.001_bib89","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1194\/jlr.M400438-JLR200","article-title":"Phosphatidylinositol increases HDL-C levels in humans","volume":"46","author":"Burgess","year":"2005","journal-title":"J Lipid Res"},{"key":"10.1016\/j.numecd.2007.05.001_bib90","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1067\/mhj.2002.119997","article-title":"Policosanol: clinical pharmacology and therapeutic significance of a new lipid-lowering agent","volume":"143","author":"Gouni-Berthold","year":"2002","journal-title":"Am Heart J"},{"key":"10.1016\/j.numecd.2007.05.001_bib91","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1093\/ajcn\/84.5.1003","article-title":"Lack of cholesterol-lowering efficacy of Cuban sugar cane policosanols in hypercholesterolemic persons","volume":"84","author":"Kassis","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.numecd.2007.05.001_bib92","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1001\/jama.295.19.2262","article-title":"Effect of policosanol on lipid levels among patients with hypercholesterolemia or combined hyperlipidemia: a randomized controlled trial","volume":"295","author":"Berthold","year":"2006","journal-title":"Jama"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475307001135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475307001135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,22]],"date-time":"2021-08-22T03:23:56Z","timestamp":1629602636000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475307001135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":92,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S0939475307001135"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2007.05.001","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}